The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

Cardiovascular Engineering and Technology, published by SPRINGER, stands as a prominent journal in the fields of Biomedical Engineering and Cardiology. With an ISSN of 1869-408X, this journal bridges the gap between engineering innovation and cardiovascular health by exploring the latest advancements pertinent to cardiovascular technologies and therapies. The journal, currently in its converged years from 2010 to 2024, holds important positions in Quartile 3 of both Biomedical Engineering and Cardiology and Cardiovascular Medicine categories, highlighting its relevance and influence in these domains. Ranked in the 59th percentile for Cardiology and 42nd percentile for Biomedical Engineering, the journal is a valuable resource for researchers, professionals, and students keen on understanding the intersection of engineering solutions and cardiovascular medicine. Although the journal is not open access, it remains highly regarded for its rigorous peer-reviewed content that contributes to the advancement of technology in the cardiovascular field.

Biomedical Engineering Letters, published by SpringerNature, is a prominent journal in the field of Biomedical Engineering. With a robust ISSN of 2093-9868 and E-ISSN of 2093-985X, this esteemed journal has established itself as a vital resource for researchers and professionals seeking to advance their knowledge and share groundbreaking findings. Recognized for its quality, Biomedical Engineering Letters holds a distinguished ranking in Scopus, positioned at #94/303 (69th percentile) in the Biomedical Engineering category. The journal covers a diverse scope within biomedical engineering, providing an important platform for innovative research from 2011 to 2024 and facilitating the exchange of ideas among scholars. Although it operates under a subscription model, the journal's commitment to enhancing the field makes it an indispensable reference for those engaged in cutting-edge biomedical research in Germany and globally.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

Biomedical Signal Processing and Control is a premier academic journal published by ELSEVIER SCI LTD that stands at the forefront of the rapidly evolving fields of biomedical engineering, health informatics, and signal processing. With an impressive impact factor reflecting its scholarly influence and high standards of research, this journal has been recognized in the Q1 quartile category across multiple disciplines as of 2023. Specifically, it holds esteemed positions within Biomedical Engineering, Health Informatics, and Signal Processing, where it ranks in the top tier of its field on Scopus: #19/131, #21/138, and #47/303 respectively. Published continually from 2006 to 2024, the journal serves as a critical platform for researchers, healthcare professionals, and students, fostering innovation in signal processing techniques and their applications in biomedical systems. Access to cutting-edge research and methodologies makes it an indispensable resource for advancing knowledge and practice within these interdisciplinary domains.

Computer Methods and Programs in Biomedicine, published by ELSEVIER IRELAND LTD, is a leading journal at the intersection of computer science and biomedical research. With an impressive impact factor evidenced by its Q1 rankings in multiple categories—Computer Science Applications, Health Informatics, and Software—this journal ranks highly among peer publications, showcasing its significance in advancing interdisciplinary research. Covering a wide array of topics since its inception in 1985, it is particularly crucial for those invested in the innovation of computational methods applied to the biomedical field. The journal has established a strong reputation, with Scopus rankings placing it in the top percentiles across its relevant sectors, including the 14th position out of 138 in Health Informatics. Researchers, practitioners, and students looking to explore current trends, methodologies, and advancements in biomedical applications of computer science will find this journal an invaluable resource.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

Biomedical Engineering-Biomedizinische Technik, published by WALTER DE GRUYTER GMBH, serves as a pivotal platform for advancing knowledge in the field of biomedical engineering and medicine since its inception in 1956. With an ISSN of 0013-5585 and an E-ISSN of 1862-278X, this peer-reviewed journal offers accessible insights into innovative research and technological advancements that are reshaping healthcare practices and biomedical applications. Although rated in the Q3 category for both Biomedical Engineering and Miscellaneous Medicine in 2023, the journal's impact factor and growing reputation demonstrate its vital role in fostering academic dialogue and collaboration. The journal is based in Germany, while its scope encompasses a diverse range of topics, thus bridging the gap between engineering and medical disciplines. Researchers, professionals, and students alike are encouraged to engage with the content that not only highlights contemporary challenges but also presents groundbreaking solutions in biomedical technology.